Hansoh Pharmaceutical Group Future Growth
Future criteria checks 2/6
Hansoh Pharmaceutical Group is forecast to grow earnings and revenue by 8.6% and 9.1% per annum respectively. EPS is expected to grow by 8.4% per annum. Return on equity is forecast to be 12.6% in 3 years.
Key information
8.6%
Earnings growth rate
8.4%
EPS growth rate
Pharmaceuticals earnings growth | 27.6% |
Revenue growth rate | 9.1% |
Future return on equity | 12.6% |
Analyst coverage | Good |
Last updated | 05 Jun 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 13,978 | 4,416 | 4,189 | 4,459 | 13 |
12/31/2025 | 12,478 | 3,790 | 3,912 | 3,710 | 21 |
12/31/2024 | 11,830 | 3,773 | 3,539 | 3,354 | 20 |
12/31/2023 | 10,104 | 3,278 | 2,754 | 3,116 | N/A |
9/30/2023 | 9,782 | 2,926 | 2,292 | 2,615 | N/A |
6/30/2023 | 9,459 | 2,575 | 1,830 | 2,114 | N/A |
3/31/2023 | 9,421 | 2,579 | 2,140 | 2,427 | N/A |
12/31/2022 | 9,382 | 2,584 | 2,449 | 2,741 | N/A |
9/30/2022 | 9,675 | 2,652 | 2,646 | 3,004 | N/A |
6/30/2022 | 9,968 | 2,720 | 2,842 | 3,267 | N/A |
3/31/2022 | 9,952 | 2,717 | 2,472 | 2,922 | N/A |
12/31/2021 | 9,935 | 2,713 | 2,102 | 2,577 | N/A |
9/30/2021 | 9,524 | 2,675 | 1,415 | 2,345 | N/A |
6/30/2021 | 9,112 | 2,638 | 729 | 2,113 | N/A |
3/31/2021 | 8,901 | 2,603 | 840 | 2,252 | N/A |
12/31/2020 | 8,690 | 2,569 | 951 | 2,390 | N/A |
9/30/2020 | 8,377 | 2,526 | 1,775 | 2,802 | N/A |
6/30/2020 | 8,063 | 2,483 | 2,600 | 3,213 | N/A |
3/31/2020 | 8,373 | 2,520 | 2,666 | 3,271 | N/A |
12/31/2019 | 8,683 | 2,557 | 2,732 | 3,330 | N/A |
9/30/2019 | 8,615 | 2,357 | 2,529 | 3,092 | N/A |
6/30/2019 | 8,548 | 2,157 | 2,325 | 2,854 | N/A |
3/31/2019 | 8,135 | 2,030 | 2,008 | 2,463 | N/A |
12/31/2018 | 7,722 | 1,903 | 1,690 | 2,072 | N/A |
12/31/2017 | 6,186 | 1,595 | 1,139 | 1,402 | N/A |
12/31/2016 | 5,433 | 1,476 | N/A | 1,247 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HNSP.F's forecast earnings growth (8.6% per year) is above the savings rate (2.4%).
Earnings vs Market: HNSP.F's earnings (8.6% per year) are forecast to grow slower than the US market (14.8% per year).
High Growth Earnings: HNSP.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: HNSP.F's revenue (9.1% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: HNSP.F's revenue (9.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HNSP.F's Return on Equity is forecast to be low in 3 years time (12.6%).